Bank of America
MATN

Bank of America’s Mateon Therapeutics, Inc. MATN Stock Holding History

Bank of America’s Portfolio MATN Stock Details MATN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,557
Closed -$2K – 7631
2016
Q3 		$2K Buy
2,557
+1,980
+343% +$1.34K ﹤0.01% 6890
2016
Q2 		$0 Buy
+577
New +$409 ﹤0.01% 7638

Other funds holding MATN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of America's MATN Position: Q4 2016 in Review

Bank of America sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 2,557 shares — an estimated $2K sold.

Bank of America first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $2K in Q3 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

  • Bank of America reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • Bank of America sold 2,557 Mateon Therapeutics, Inc. shares in Q4 2016, an estimated $2K.
  • Bank of America first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
  • Bank of America's Mateon Therapeutics, Inc. position peaked at $2K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Bank of America's 13F filing for Q4 2016, filed 14 Feb 2017.